[Federal Register Volume 62, Number 45 (Friday, March 7, 1997)] [Notices] [Page 10584] From the Federal Register Online via the Government Publishing Office [www.gpo.gov] [FR Doc No: 97-5596] ----------------------------------------------------------------------- DEPARTMENT OF JUSTICE Notice Pursuant to the National Cooperative Research and Production Act of 1993 Consortium for Plasma Science, LLC Notice is hereby given that, on February 5, 1997, pursuant to Section 6(a) of the National Cooperative Research and Production Act of 1993, 15 U.S.C. 4301 et seq. (``the Act''), the Consortium for Plasma Science, LLC has filed written notifications simultaneously with the Attorney General and the Federal Trade Commission disclosing (1) the identities of the parties and (2) the nature and objective of the venture. The notifications were filed for the purpose of invoking the Act's provisions limiting the recovery of antitrust plaintiffs to actual damages under specified circumstances. Pursuant to Section 6(b) of the Act, the identities of the parties are Alpha Therapeutic Corporation, Los Angeles, CA; Baxter Healthcare Corporation, Deerfield, IL; Bayer Corporation, West Haven CN; Centeon L.L.C., King of Prussia, PA; and NABI, Boca Raton, CA. The general area of planned activity is to develop, promote and conduct research and development to address improvements in safety in blood plasma and blood plasma products. Constance K. Robinson, Director of Operations Antitrust Division. [FR Doc. 97-5596 Filed 3-6-97; 8:45 am] BILLING CODE 4410-11-M